Keyphrases
Programmed Death-ligand 1 (PD-L1)
100%
Upper Tract Urothelial Carcinoma
100%
Histological Variants
100%
Molecular Subtypes
100%
Immune Markers
100%
Tumor Microenvironment
60%
Urothelial Carcinoma
40%
CD-8
40%
Checkpoint Inhibitors
40%
PD-L1 Expression
40%
Tumor
20%
Marker Expression
20%
Immunohistochemistry
20%
Bladder Cancer
20%
Chronic Inflammation
20%
Histological Subtypes
20%
Poor Prognosis
20%
CD68
20%
Tissue Microarray
20%
Marker Score
20%
Durable Response
20%
Immune Infiltration
20%
Immune Checkpoint Inhibitors
20%
Intratumoral Heterogeneity
20%
Advanced Bladder Cancer
20%
Tumor-infiltrating Immune Cells
20%
Higher Groups
20%
Medicine and Dentistry
Transitional Cell Carcinoma
100%
Immunity
100%
Programmed Death-Ligand 1
100%
Tumor Microenvironment
60%
CD3 Antigen
60%
Neoplasm
40%
Bladder Cancer
40%
CD8 Antigen
40%
Immunohistochemistry
20%
Chronic Inflammation
20%
Immunocompetent Cell
20%
Chlordane
20%
Tissue Microarray
20%
Immune Checkpoint Inhibitor
20%
Immune Cell Infiltration
20%
Biochemistry, Genetics and Molecular Biology
Immunity
100%
PD-L1
100%
CD8
33%
CD68
16%
Immunocompetent Cell
16%
Tissue Microarray
16%
Immune Checkpoints
16%